Cryo-Cell International (NYSEAMERICAN:CCEL) Stock Price Crosses Above 50-Day Moving Average – Here’s Why

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL)’s stock price crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.00 and traded as high as $7.60. Cryo-Cell International shares last traded at $7.40, with a volume of 28,467 shares.

Cryo-Cell International Trading Down 4.1 %

The firm has a market capitalization of $59.64 million, a PE ratio of -6.98 and a beta of 0.49.

Cryo-Cell International (NYSEAMERICAN:CCEL) last issued its earnings results on Tuesday, October 15th. The company reported $0.13 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.11. Cryo-Cell International had a negative return on equity of 42.06% and a negative net margin of 28.03%. The business had revenue of $8.07 million for the quarter.

Cryo-Cell International Dividend Announcement

The company also recently announced a — dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were issued a $0.25 dividend. The ex-dividend date of this dividend was Friday, November 15th. Cryo-Cell International’s payout ratio is -94.34%.

Institutional Investors Weigh In On Cryo-Cell International

A hedge fund recently raised its stake in Cryo-Cell International stock. Geode Capital Management LLC boosted its stake in shares of Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) by 68.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,860 shares of the company’s stock after buying an additional 16,203 shares during the quarter. Geode Capital Management LLC owned 0.49% of Cryo-Cell International worth $254,000 as of its most recent SEC filing. Institutional investors own 10.44% of the company’s stock.

About Cryo-Cell International

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.